BDKRB1 and infection: Since the B1R antagonist reduced the extent of heart parasitism during the acute stage of infection, we then shifted the time window of R-954 treatment to the chronic stage of infection (120–160 dpi; Figure 4A), hence, covering the period in which heart injury consistently causes electrical disturbances [52] (Figure 4B).